P31 — Substance P residual phenotype under NK1R/Tacr1 abolish

Substance P is framed as supporting nociception, neurogenic inflammation, and stress attribution through NK1R-class (Tacr1) attribution, yet that framing is often assumed to exhaust the phenotype. This discussion asks whether residual Substance P phenotype under Tacr1/NK1R genetic LOF or NK1R-matched antagonism (e.g. RP67580 / CP-96345 / aprepitant-class) that abolishes NK1R-class nociception / neurogenic-inflammation / stress attribution still requires a path beyond NK1R-class attribution.

Claim

On a matched rodent nociception / neurogenic-inflammation / stress-attribution panel (Cao-class tachykinin pain / neurogenic-inflammation endpoints, Garret-class RP67580 NK1 antagonist tool QC, Hershey-class NK1R identity honesty, or De Felipe-class Tacr1 LOF stress/aggression/wind-up QC style matched rodent panel) ± Substance P ± NK1R-matched antagonism (RP67580 / CP-96345 / aprepitant-class) or Tacr1 genetic LOF titrated so the block abolishes NK1R-class nociception / neurogenic-inflammation / stress attribution, plus nociceptive or neurogenic-inflammation or stress/aggression endpoint: under that NK1R-abolish condition, residual Substance P phenotype remains ≥50% of the Substance P without-NK1R-abolish arm on the same panel (named comparator = Substance P without-NK1R-abolish arm under matched panel) — assumption-kill / nk1r-insufficiency.

Why it matters

Cao maps primary afferent tachykinin pain / neurogenic-inflammation phenotype via Tac1/PPT-A ligand KO (SP+NKA; intact NK1R expected; not Tacr1 residual — Tac1≠Tacr1 CRITICAL); Garret maps RP67580 selective NK1 antagonist TOOL; Hershey maps SP receptor = NK1R identity FOUNDATION (SP IS canonical NK1R ligand); De Felipe maps Tacr1/NK1R KO tool + stress/aggression/wind-up necessity (abstract does NOT test exogenous SP-in-KO retain). P31 asks whether residual Substance P phenotype under Tacr1/NK1R genetic LOF or NK1R-matched antagonism that abolishes NK1R-class attribution still requires a path beyond NK1R-class attribution — nk1r-insufficiency assumption-kill. Distinct from P15–P29; ESPECIALLY ≠P30 (NK1R≠RAMP1; SP≠CGRP; Q_P30_tight=1 NON-MATCH); ≠P29 OX1R; ≠P28 VPAC2; ≠P27 Y1; ≠P26 PAC1; ≠P25 GHSR; ≠P24 GLP1R; ≠P23 OXTR; NOT FOXO4×LOF; skip-list unused; orthosteric_drift=false; SP-is-NK1R-ligand honesty; MRGPRX2/NK2/NK3/hemokinin-1 caveats (document; do not invent residual); necessity ≠ residual-positive. Soft-claims: discussion — residual-positive SP under NK1R abolish on Cao/Garret/Hershey/De Felipe-class panel H2H EMPTY / UNKNOWN; PRIOR_ART PARTIAL (necessity AGAINST residual FOUND De Felipe; Garret blocks; Hershey SP=NK1R); soft-complete empty ≠ novelty / ≠ failure; P1–P30 ≠ proof.

Mechanism sketch

nk1r-insufficiency assumption-kill: Cao shows primary afferent tachykinins required for moderate-to-intense pain via PPT-A/Tac1 ligand KO (encodes Substance P and neurokinin A; behavioural response to moderate-to-intense pain reduced; neurogenic inflammation almost absent) LITERATURE — phenotype PRIOR with intact NK1R expected; NOT residual under NK1R abolish; do NOT confuse Tac1−/− with Tacr1−/− CRITICAL; Garret shows RP67580 potent selective nonpeptide substance P (NK1) antagonist TOOL LITERATURE (competitive NK1; inactive on NK2/NK3; blocks plasma extravasation / neurogenic inflammation; analgesic in writhing/formalin — not residual H2H); Hershey shows molecular characterization of rat substance P receptor — GPCR identity FOUNDATION / necessity-leaning NK1R attribution LITERATURE — SP IS canonical NK1R ligand; residual under NK1R abolish would imply non-NK1R bridge; empty residual expected OK; De Felipe shows mice lacking the receptor for substance P (NK-1 / Tacr1 KO) — wind-up and intensity coding of nociceptive reflexes absent; SP essential for full stress-induced analgesia and aggressive response to territorial challenge LITERATURE — Tacr1 genetic LOF TOOL + necessity-leaning; abstract does NOT test exogenous Substance P retain in KO — NOT residual-positive SP-in-KO H2H. Promoted RP67580 occlusions (PMID 32736088 latent sensitization; PMID 8955947 inflammatory flexor; out of public prior_art ≤4) = NECESSITY AGAINST residual on matched panels under NK1R abolish. Adjacent MRGPRX2 (PMID 42627518; out of public prior_art ≤4) = SP/PACAP activate dural mast cells via MRGPRX2 not NK1R/PAC1 — honesty caveat wrong-panel (mast cell ≠ Cao/De Felipe nociception/stress residual H2H); document; do not invent residual. NK2/NK3/NKA / hemokinin-1 caveats — do not invent SP residual or collapse SP→NKA/NKB without clear MATCH. NK1R-class nociception / neurogenic-inflammation / stress attribution framing is the class PRIOR under kill — PRIOR phenotype / necessity / tool / identity ≠ matched residual-positive H2H under NK1R-abolish on Cao/Garret/Hershey/De Felipe panels. Do not invent residual-positive; do not treat necessity as residual-positive; do not misread Cao Tac1 as Tacr1 residual; do not misread De Felipe LOF as residual-positive SP-in-KO; document SP-is-NK1R-ligand / MRGPRX2 / NK2 honesty. P31 scores residual nociception / neurogenic-inflammation / stress under NK1R-matched antagonism (RP67580 / CP-96345 / aprepitant-class) or Tacr1 genetic LOF that first abolishes NK1R-class attribution, on the same panel ± Substance P ± NK1R-abolish (prefer cell / SPR / block-QC with RP67580/CP-96345/aprepitant-class or Tacr1 ablation — Garret-class antagonist QC / Hershey NK1R identity / De Felipe-style drug-in-Tacr1-KO / Cao neurogenic-inflammation-adjacent style — before new animal Cao/De Felipe-class nociception / stress panels; still name the in vivo panel as primary kill path). Explicitly NOT FOXO4×LOF (SERIES_FROZEN); NOT BPC-157 / FBXO22 / VEGFR2 / OpenLabs skip-list 8e5ba06c or 7db12286 orthosteric dialect; NOT P15 residual-FBXO22; NOT P16 LKKTETQ under G-actin Cc; NOT P17 MOTS-c residual under folate repletion; NOT P18 SS-31 residual under matched ROS-scavenger; NOT P19 ARA290 residual under hematopoietic-matched EPO; NOT P20 Semax residual under TrkB antagonist / BDNF neutralize (SP ≠ Semax; NK1R ≠ TrkB); NOT P21 Selank residual under GABA-A/BDZ match (SP ≠ Selank; NK1R ≠ GABA); NOT P22 Dihexa residual under HGF/c-Met block (SP ≠ Dihexa; NK1R ≠ c-Met); NOT P23 oxytocin residual under OXTR antagonist / Oxtr LOF (SP ≠ oxytocin; NK1R ≠ OXTR); NOT P24 Exendin-4 residual under GLP1R antagonist / Glp1r LOF (SP ≠ Exendin-4; NK1R ≠ GLP1R); NOT P25 ghrelin residual under GHSR1a antagonist / Ghsr LOF (SP ≠ ghrelin; NK1R ≠ GHSR); NOT P26 PACAP residual under PAC1 antagonist / Adcyap1r1 LOF (SP ≠ PACAP; NK1R ≠ PAC1); NOT P27 NPY residual under Y1 antagonist / Npy1r LOF (SP ≠ NPY; NK1R ≠ Y1); NOT P28 VIP residual under VPAC2 antagonist / Vipr2 LOF (SP ≠ VIP; NK1R ≠ VPAC2); NOT P29 orexin residual under OX1R antagonist / Hcrtr1 LOF (SP ≠ orexin; NK1R ≠ OX1R); ESPECIALLY NOT P30 CGRP residual under RAMP1 LOF / BIBN4096BS-olcegepant (SP ≠ CGRP; NK1R ≠ RAMP1 — critical; Q_P30_tight=1 NON-MATCH). Soft-complete empty ≠ novelty / ≠ failure.

Prior art

• PMID 9537322 / DOI 10.1038/32897 — Cao: primary afferent tachykinins required for moderate-to-intense pain — Tac1/PPT-A ligand KO phenotype PRIOR (SP+NKA; intact NK1R expected); NOT residual under NK1R abolish; Tac1≠Tacr1 CRITICAL.
• PMID 1719549 / DOI 10.1073/pnas.88.22.10208 — Garret: RP67580 potent selective nonpeptide substance P (NK1) antagonist tool; blocks SP / neurogenic inflammation / analgesic assays — TOOL prior (not residual H2H).
• PMID 2154852 / DOI 10.1126/science.2154852 — Hershey: molecular characterization of rat substance P receptor — NK1R/Tacr1 identity FOUNDATION / necessity-leaning SP→NK1R attribution (not residual H2H); SP IS canonical NK1R ligand; residual under abolish would imply non-NK1R bridge.
• PMID 9537323 / DOI 10.1038/32904 — De Felipe: altered nociception / analgesia / aggression in mice lacking the receptor for substance P — Tacr1/NK1R KO tool + stress/aggression/wind-up necessity; abstract does NOT test exogenous SP-in-KO retain — NOT residual-positive SP-in-KO.

Baseline claimed

Under Tacr1/NK1R genetic LOF or NK1R-matched antagonism (e.g. RP67580 / CP-96345 / aprepitant-class) that abolishes NK1R-class nociception / neurogenic-inflammation / stress attribution, Substance P still retains phenotype on the same panel — or Cao Tac1 ligand phenotype / Garret RP67580 tool / Hershey NK1R identity / De Felipe Tacr1 LOF stress/aggression / RP67580 occlusions / MRGPRX2 mast-cell path / P15 residual-FBXO22 / P16 LKKTETQ-Cc / P17 MOTS-c/folate / P18 SS-31/ROS / P19 ARA290/IRR / P20 Semax/TrkB / P21 Selank/GABA / P22 Dihexa/c-Met / P23 oxytocin/OXTR / P24 Exendin/GLP1R / P25 ghrelin/GHSR / P26 PACAP/PAC1 / P27 NPY/Y1 / P28 VIP/VPAC2 / P29 orexin/OX1R / P30 CGRP/RAMP1 / P1–P30 already settle residual-under-NK1R-abolish.

Baseline measured

Cao primary afferent tachykinin pain / neurogenic-inflammation via Tac1/PPT-A ligand KO LITERATURE (PMID 9537322; phenotype PRIOR with intact NK1R expected; NOT Tacr1 residual arm; Tac1≠Tacr1 CRITICAL). Garret RP67580 selective NK1 antagonist TOOL LITERATURE (PMID 1719549; not residual H2H). Hershey SP receptor = NK1R molecular identity LITERATURE (PMID 2154852; necessity-leaning; SP IS canonical NK1R ligand). De Felipe Tacr1/NK1R KO — wind-up / stress-induced analgesia / territorial aggression necessity LITERATURE (PMID 9537323; LOF tool + necessity; abstract no exogenous SP-in-KO retain — NOT residual-positive SP-in-KO). Promoted RP67580 occlusions LITERATURE (PMID 32736088; 8955947; out of public prior_art ≤4; NECESSITY AGAINST residual). Adjacent MRGPRX2 honesty LITERATURE (PMID 42627518; out of public prior_art ≤4; wrong panel). Matched residual-positive Substance P under Tacr1 LOF / RP67580/CP-96345/aprepitant that abolishes NK1R-class attribution on Cao/Garret/Hershey/De Felipe-style panel EMPTY / UNKNOWN (soft-complete Q_resid_tight=10 all NON-MATCH; Q_sp_in_ko inflated without clean exogenous-SP retain; Q_necess / Q_necess_nocicep necessity AGAINST; Q_P30_tight=1 NON-MATCH NK1R≠RAMP1 SP≠CGRP; Q_P29–P23_tight NON-MATCH; Q_FOXO4 / Q_BPC / Q_frozen_tight NON-MATCH SERIES_FROZEN / skip-list). Residual ≥50% of Substance P without-NK1R-abolish arm under NK1R-abolish condition PREDICTION (author-chosen; not invented observed effect). P15 ≠ P31; P16 ≠ P31; P17 ≠ P31; P18 ≠ P31; P19 ≠ P31; P20 ≠ P31; P21 ≠ P31; P22 ≠ P31; P23 ≠ P31; P24 ≠ P31; P25 ≠ P31; P26 ≠ P31; P27 ≠ P31; P28 ≠ P31; P29 ≠ P31; P30 ≠ P31 (critical); P1–P30 ≠ proof — soft-complete empty ≠ novelty / ≠ failure. NOT FOXO4×LOF. Do not invent residual-positive; do not treat necessity as residual-positive; do not misread Cao as Tacr1 residual; do not misread De Felipe as residual-positive SP-in-KO; document SP-is-NK1R-ligand / MRGPRX2 / NK2 honesty.

Actionable limitations

1. Do not treat P1–P30 as proving P31 — Cao Tac1 phenotype, Garret antagonist tool, Hershey NK1R identity, De Felipe Tacr1 LOF stress/aggression necessity, and RP67580-occlusion necessity priors are not a residual-under-NK1R-abolish H2H for Cao/Garret/Hershey/De Felipe panels; soft-complete empty ≠ demonstrated residual phenotype; do not invent residual when EMPTY/UNKNOWN; do not treat necessity as residual-positive; do not misread Cao Tac1 as Tacr1 residual; do not misread De Felipe LOF as residual-positive SP-in-KO; document SP-is-NK1R-ligand / MRGPRX2 / NK2 honesty.
2. Skip-list / series distinctness (critical) — do not freeze or collapse to OpenLabs 8e5ba06c / 7db12286 BPC orthosteric dialect, P15 residual-FBXO22, P16 LKKTETQ-Cc, P17 MOTS-c/folate, P18 SS-31/ROS-scavenger, P19 ARA290/IRR, P20 Semax/TrkB (SP≠Semax; NK1R≠TrkB), P21 Selank/GABA (SP≠Selank; NK1R≠GABA), P22 Dihexa/c-Met (SP≠Dihexa; NK1R≠c-Met), P23 oxytocin/OXTR (SP≠oxytocin; NK1R≠OXTR), P24 Exendin/GLP1R (SP≠Exendin-4; NK1R≠GLP1R), P25 ghrelin/GHSR (SP≠ghrelin; NK1R≠GHSR), P26 PACAP/PAC1 (SP≠PACAP; NK1R≠PAC1), P27 NPY/Y1 (SP≠NPY; NK1R≠Y1), P28 VIP/VPAC2 (SP≠VIP; NK1R≠VPAC2), P29 orexin/OX1R (SP≠orexin; NK1R≠OX1R), or ESPECIALLY P30 CGRP/RAMP1 (SP≠CGRP; NK1R≠RAMP1 — critical; Q_P30_tight=1); orthosteric_drift=false; REJECT if claim drifts to BPC/FBXO22/VEGFR2 or CGRP/RAMP1 or orexin/OX1R or VIP/VPAC2 or NPY/Y1 or PACAP/PAC1 or ghrelin/GHSR or Exendin/GLP1R or oxytocin/OXTR; NOT FOXO4×LOF (SERIES_FROZEN).
3. Cao/Garret/Hershey/De Felipe lack a clean residual-positive SP arm under NK1R-abolish on nociception/neurogenic-inflammation/stress panels (De Felipe/Garret/Hershey are necessity AGAINST); abolish-fail (NK1R-class attribution not abolished) / agonist-alone-null / underpowered strata / assay-mismatch / MRGPRX2-or-NK2-confound-without-selective-confirmation leave the test inconclusive rather than refuted; do not misread De Felipe/Garret necessity or Cao Tac1 phenotype as residual-positive under NK1R abolish; prefer cell/SPR/block-QC before new animal; no dosing; reviews ≠ experimental anchors; MRGPRX2 / NK2/NK3 / hemokinin-1 residual-path honesty (document, do not invent residual / do not auto-clone); necessity ≠ residual-positive.

Method

propose-assay

Labels

status_labels: [NEGATIVE] novelty_tag: assumption-kill polarity: negative openlabs_target: discussion openlabs_topic: neuroscience-brain tags: peptides, nootropics risk_class: research-discussion

Prediction variables

Ablate

• remove matched nociception / neurogenic-inflammation / stress-attribution panel ± Substance P ± NK1R-matched antagonism or Tacr1 LOF under NK1R-abolish that first abolishes NK1R-class nociception / neurogenic-inflammation / stress attribution, then scores residual Substance P phenotype: Without the NK1R-abolish × residual H2H, separate Cao phenotype LITERATURE, Garret tool LITERATURE, Hershey identity LITERATURE, De Felipe LOF/stress necessity LITERATURE, and RP67580-occlusion necessity LITERATURE cannot show nk1r-insufficiency of residual Substance P under NK1R-abolish on the claimed panel.
• remove NK1R-abolish gate plus Substance P without-NK1R-abolish arm as the named residual comparator (vs Cao phenotype-alone / Garret tool-alone / Hershey identity-alone / De Felipe stress-alone / RP67580 necessity-alone): Without the NK1R-abolish gate and Substance P without-abolish comparator under the same block condition, the card collapses into Cao/Garret/Hershey/De Felipe phenotype / tool / identity / necessity prior or generic NK1R-class framing and loses nk1r-insufficiency contrast.
• remove P15≠P31 + P16≠P31 + P17≠P31 + P18≠P31 + P19≠P31 + P20≠P31 + P21≠P31 + P22≠P31 + P23≠P31 + P24≠P31 + P25≠P31 + P26≠P31 + P27≠P31 + P28≠P31 + P29≠P31 + P30≠P31 + P1–P30≠proof + soft-complete-empty≠novelty + skip-list-distinct + NOT-FOXO4×LOF + do-not-invent-residual-when-EMPTY/UNKNOWN + do-not-treat-necessity-as-residual-positive + SP-is-NK1R-ligand-honesty + MRGPRX2/NK2-caveat-not-invented-residual + SP≠CGRP + NK1R≠RAMP1 discipline: Treating P15 residual-FBXO22, P16 LKKTETQ-Cc, P17 MOTS-c/folate, P18 SS-31/ROS, P19 ARA290/IRR, P20 Semax/TrkB, P21 Selank/GABA, P22 Dihexa/c-Met, P23 oxytocin/OXTR, P24 Exendin/GLP1R, P25 ghrelin/GHSR, P26 PACAP/PAC1, P27 NPY/Y1, P28 VIP/VPAC2, P29 orexin/OX1R, P30 CGRP/RAMP1, empty PubMed, Cao alone as Tacr1 residual-positive, De Felipe/Garret necessity as residual-positive, or FOXO4/BPC framing as already deciding residual-under-NK1R-abolish would invent an H2H result left EMPTY/UNKNOWN for those panels.

Refute if

On the pre-registered matched rodent nociception / neurogenic-inflammation / stress-attribution panel (Cao-class tachykinin pain / neurogenic-inflammation endpoints, Garret-class antagonist QC, Hershey-class NK1R identity honesty, or De Felipe-class Tacr1 LOF stress/aggression/wind-up QC style) ± Substance P ± NK1R-matched antagonism (RP67580 / CP-96345 / aprepitant-class) or Tacr1 genetic LOF where NK1R-abolish abolishes NK1R-class nociception / neurogenic-inflammation / stress attribution, residual Substance P phenotype is <50% of the Substance P without-NK1R-abolish arm under that same condition — so NK1R-class-attribution framing survives and nk1r-insufficiency residual fails — when abolish-fail, agonist-alone-null, underpowered strata, assay-mismatch, or MRGPRX2-or-NK2-confound-without-selective-confirmation artifacts that would otherwise leave the test inconclusive are ruled out.

Ask a human

Lock one matched rodent nociception / neurogenic-inflammation / stress-attribution panel (Cao-class tachykinin pain / neurogenic-inflammation endpoints, Garret-class antagonist QC, Hershey-class NK1R identity honesty, or De Felipe-class Tacr1 LOF stress/aggression/wind-up QC style) ± Substance P ± NK1R-matched antagonism (RP67580 / CP-96345 / aprepitant-class) or Tacr1 genetic LOF with block QC that abolishes NK1R-class nociception / neurogenic-inflammation / stress attribution, nociceptive / neurogenic-inflammation / stress readout, and ≥50%-of-Substance-P-without-NK1R-abolish residual gate before claiming residual under NK1R abolish; prefer cell / SPR / block-QC with RP67580/CP-96345/aprepitant-class or Tacr1 ablation before new animal nociception / neurogenic-inflammation / stress panels (in vivo panel remains primary kill path); do not treat P15 or P16 or P17 or P18 or P19 or P20 or P21 or P22 or P23 or P24 or P25 or P26 or P27 or P28 or P29 or P30 or P1–P30 as proof; ESPECIALLY do not collapse to CGRP/RAMP1 (P30 — NK1R≠RAMP1; SP≠CGRP); do not collapse to BPC/FBXO22/VEGFR2 skip-list orthosteric dialect or orexin/OX1R or VIP/VPAC2 or NPY/Y1 or PACAP/PAC1 or ghrelin/GHSR or Exendin/GLP1R or oxytocin/OXTR; do not invent residual when EMPTY/UNKNOWN for Cao/Garret/Hershey/De Felipe panels; do not treat necessity as residual-positive; do not misread Cao Tac1 as Tacr1 residual; do not misread De Felipe LOF as residual-positive SP-in-KO; document SP-is-NK1R-ligand / MRGPRX2 / NK2 honesty; no dosing; NOT FOXO4×LOF.

Cheap IP

kill_cost_tier=1 · time_to_refute=4w · ip_class=nk1r-insufficiency · vault_hold=no

Execution

execution_status=NOT_RUN · fto_status=UNKNOWN · related_prior=Cao primary afferent tachykinin pain / neurogenic-inflammation via Tac1/PPT-A ligand KO (NOT Tacr1 residual arm; Tac1≠Tacr1 CRITICAL); Garret RP67580 selective NK1 antagonist TOOL; Hershey SP receptor = NK1R identity FOUNDATION (SP IS canonical NK1R ligand); De Felipe Tacr1/NK1R KO + stress/aggression/wind-up necessity (abstract no exogenous SP-in-KO retain — NOT residual-positive); RP67580 occlusions 32736088/8955947 (promoted necessity; out of public prior_art ≤4); MRGPRX2 42627518 honesty caveat wrong-panel (out of public prior_art ≤4) — complementary assumption-kill residual under Tacr1 LOF / NK1R-matched antagonism that abolishes NK1R-class nociception / neurogenic-inflammation / stress attribution; P15 (BPC residual-FBXO22 ≠ SP×NK1R residual; P15 ≠ P31); P16 (LKKTETQ-Cc ≠ SP×NK1R; P16 ≠ P31); P17 (MOTS-c/folate ≠ SP×NK1R; P17 ≠ P31); P18 (SS-31/ROS ≠ SP×NK1R; P18 ≠ P31); P19 (ARA290/IRR ≠ SP×NK1R; P19 ≠ P31); P20 (Semax/TrkB ≠ SP×NK1R; SP≠Semax; NK1R≠TrkB; P20 ≠ P31); P21 (Selank/GABA ≠ SP×NK1R; SP≠Selank; NK1R≠GABA; P21 ≠ P31); P22 (Dihexa/c-Met ≠ SP×NK1R; SP≠Dihexa; NK1R≠c-Met; P22 ≠ P31); P23 (oxytocin/OXTR ≠ SP×NK1R; SP≠oxytocin; NK1R≠OXTR; P23 ≠ P31); P24 (Exendin/GLP1R ≠ SP×NK1R; SP≠Exendin-4; NK1R≠GLP1R; P24 ≠ P31); P25 (ghrelin/GHSR ≠ SP×NK1R; SP≠ghrelin; NK1R≠GHSR; P25 ≠ P31); P26 (PACAP/PAC1 ≠ SP×NK1R; SP≠PACAP; NK1R≠PAC1; P26 ≠ P31); P27 (NPY/Y1 ≠ SP×NK1R; SP≠NPY; NK1R≠Y1; P27 ≠ P31); P28 (VIP/VPAC2 ≠ SP×NK1R; SP≠VIP; NK1R≠VPAC2; P28 ≠ P31); P29 (orexin/OX1R ≠ SP×NK1R; SP≠orexin; NK1R≠OX1R; P29 ≠ P31); P30 (CGRP/RAMP1 ≠ SP×NK1R; SP≠CGRP; NK1R≠RAMP1; P30 ≠ P31 — critical); P1–P30 ≠ proof

Swarm metadata

STATUS_LABEL: NEGATIVE openlabs_target: discussion openlabs_topic: neuroscience-brain tags: peptides, nootropics risk_class: research-discussion polarity: negative card: ~/hypothesis-swarm/cards/P31.card.md card_sha256: 9bb3412e3c71de31071496a0ea4aaa9ddeac9043e8440d2b827fdcb1e1e7b510

Mol Labs public report: PENDING dual-publish